| Name | Title | Contact Details |
|---|---|---|
Daniel Babb |
Senior Vice President of Technology | Profile |
Envoy is a full service digital experience consultancy. We use the power of design, technology and data to create business impact. We build connected brand, commerce, web, product and environmental experiences.
We partner with founders & CEOs of the world`s most innovative companies to realize transformational growth through excellence in marketing. Together we will build the world`s most influential brands.
As performance marketers immersed in the thick of customer acquisition in the early days of Zulily, we were knee deep in the gritty, manual labor required to hit our growth goals – on a daily basis. We knew we could achieve greater successes if we could scale our efforts – work 24/7, continuously optimize and manage an infinite number of variables. But among the myriad CRM and marketing SaaS products on the market, there was no single solution that could truly scale performance. So we built one. New Engen has grown into a full service AI-driven marketing company driving performance and new customer acquisition. But we know there’s still work to be done because as marketing evolves with technology we continue to uncover new digital marketing opportunities and platforms for our clients to scale and grow.
Gokhshtein Media, a unique and leading media outlet covering digital assets, blockchain technology and lifestyle content from around the world.
Evoke is a leading marketing, media, and communications agency bound by a common purpose: Health more human™. With offices in New York, Philadelphia, San Francisco, Los Angeles, London, Dublin, Princeton, Chicago, Singapore, and Dubai, more than 700 employees proudly work with 18 of the top 20 pharmaceutical companies worldwide. Evoke is part of Huntsworth plc, an international healthcare and communications group. Huntsworth`s principal areas of focus are marketing, medical, and immersive communication services for healthcare clients, which are primarily large and mid-sized pharmaceutical and biotech companies. Clayton, Dubilier & Rice acquired Huntsworth plc on May 1, 2020.